AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34219257 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D1–25 supplementation for high-risk patients, routine daily calcium samples until 48 hours post-surgery.
Number of subjects: 66
Study 34219257 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine daily calcium samples for low-risk patients until 48 hours post-surgery.
Number of subjects: 66
Study 34219257 — intervention group
Group type: COMPARATOR
Intervention: Historical control group treated only if they presented hypocalcemia.
Number of subjects: 66
Study 32371123 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy with rituximab
Number of subjects: 160
Study 32371123 — intervention group
Group type: COMPARATOR
Intervention: Standard chemotherapy without rituximab (Control)
Number of subjects: 160
Study 32371123 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 160
Study 35671553 — intervention group
Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.4 mg/g nicotine)
Number of subjects: 58
Study 35671553 — intervention group
Group type: COMPARATOR
Intervention: Normal Nicotine Content (NNC) cigarettes (15.8 mg nicotine/g tobacco)
Number of subjects: 58
Study 32607574 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe delirium
Number of subjects: 434
Study 32607574 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 or more days of delirium or coma
Number of subjects: 434
Study 32607574 — intervention group
Group type: EXPERIMENTAL
Intervention: Delirium severity and number of days of delirium or coma
Number of subjects: 434
Study 33141624 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual speakers with PD
Number of subjects: 11
Study 33141624 — intervention group
Group type: COMPARATOR
Intervention: Bilingual controls
Number of subjects: 11
Study 33141624 — intervention group
Group type: COMPARATOR
Intervention: Native English speakers
Number of subjects: 11
Study 36471412 — intervention group
Group type: EXPERIMENTAL
Intervention: NIKA (Nederlandse Interventie Kortdurend op Atypisch oudergedrag)
Number of subjects: 150
Study 36471412 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR therapy
Number of subjects: 150
Study 36471412 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of NIKA and EMDR
Number of subjects: 150
Study 36471412 — intervention group
Group type: COMPARATOR
Intervention: Waitlist usual care group (control)
Number of subjects: 150
Study 32785726 — intervention group
Group type: EXPERIMENTAL
Intervention: Mix-and-match implantation of a diffractive extended depth of focus IOL (TECNIS Symfony ZXR00) and a diffractive bifocal IOL (TECNIS ZLB00 +3.25 diopters)
Number of subjects: 50
Study 32785726 — intervention group
Group type: COMPARATOR
Intervention: Bilateral implantation of a diffractive trifocal IOL (AcrySof IQ PanOptix)
Number of subjects: 50
Study 36428095 — intervention group
Group type: COMPARATOR
Intervention: Control messaging
Number of subjects: 2222
Study 36428095 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced risk messaging
Number of subjects: 2222
Study 36428095 — intervention group
Group type: EXPERIMENTAL
Intervention: FDA endorsement message
Number of subjects: 2222
Study 33911087 — intervention group
Group type: EXPERIMENTAL
Intervention: multimodal intervention (diet, physical activity, psychosocial support)
Number of subjects: 342
Study 33911087 — intervention group
Group type: COMPARATOR
Intervention: lifestyle recommendations (control group)
Number of subjects: 342
Study 34937780 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of cerebral microbleeds (CMBs)
Number of subjects: 466
Study 34937780 — intervention group
Group type: COMPARATOR
Intervention: No cerebral microbleeds (CMBs)
Number of subjects: 466
Study 34454119 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedaquiline-containing regimen
Number of subjects: 103
Study 34454119 — intervention group
Group type: COMPARATOR
Intervention: Bedaquiline-free regimen
Number of subjects: 103
Study 34454119 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 103
Study 36007171 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy and gas tamponade
Number of subjects: 262
Study 36007171 — intervention group
Group type: EXPERIMENTAL
Intervention: D chart distortion scores
Number of subjects: 262
Study 34903194 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light intensity setting
Number of subjects: 50
Study 34903194 — intervention group
Group type: COMPARATOR
Intervention: Medium light intensity setting
Number of subjects: 50
Study 34903194 — intervention group
Group type: COMPARATOR
Intervention: Dark light intensity setting
Number of subjects: 50
Study 33492271 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stretching (DS)
Number of subjects: 26
Study 33492271 — intervention group
Group type: COMPARATOR
Intervention: Heavy load leg press (HL)
Number of subjects: 26
Study 33023423 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase
Number of subjects: 202
Study 33023423 — intervention group
Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 202
Study 35411784 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting postoperative headache (POH)
Number of subjects: 13440
Study 33036645 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk oral stimulation
Number of subjects: 69
Study 33036645 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological saline oral stimulation
Number of subjects: 69
Study 33036645 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study 34166587 — intervention group
Group type: EXPERIMENTAL
Intervention: DR/ER-MPH (Delayed-release and extended-release methylphenidate)
Number of subjects: 0
Study 32414958 — intervention group
Group type: EXPERIMENTAL
Intervention: PsA with systemic lupus erythematosus (SLE)
Number of subjects: 4836
Study 32414958 — intervention group
Group type: COMPARATOR
Intervention: Control group (general population)
Number of subjects: 4836
Study 32414958 — intervention group
Group type: EXPERIMENTAL
Intervention: PsA patients
Number of subjects: 4836
Study 33290616 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-06826647 (doses: 3, 10, 30, 100, 200, 400, or 1,600 mg for SAD; 30, 100, 400, or 1,200 mg q.d. or 200 mg b.i.d. for 10 days for MAD)
Number of subjects: 69
Study 33290616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 33186199 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated detection of exercise sessions using an algorithm
Number of subjects: 54
Study 33186199 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-detected exercise sessions (total and intensity)
Number of subjects: 54
Study 616269767 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education, income, and socioeconomic status (SES)
Number of subjects: 4161
Study 616269767 — intervention group
Group type: EXPERIMENTAL
Intervention: SCORE algorithm for higher risk countries
Number of subjects: 4161
Study 35440611 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 210
Study 35440611 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol (Control)
Number of subjects: 210
Study 32947603 — intervention group
Group type: EXPERIMENTAL
Intervention: B. breve BBG‐001
Number of subjects: 94
Study 32947603 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 94
Study 32380069 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg or 500 mg, three times a week for 6 months
Number of subjects: 90
Study 32380069 — intervention group
Group type: COMPARATOR
Intervention: Placebo, three times a week for 6 months
Number of subjects: 90
Study 32380069 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 90
Study 35858170 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive follow-up regimen (INT)
Number of subjects: 1871
Study 35858170 — intervention group
Group type: COMPARATOR
Intervention: Minimalist follow-up regimen (MIN)
Number of subjects: 1871
Study 34738518 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day amoxicillin treatment
Number of subjects: 824
Study 34738518 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day amoxicillin treatment
Number of subjects: 824
Study 34738518 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose (35-50 mg/kg/day)
Number of subjects: 824
Study 34738518 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose (70-90 mg/kg/day)
Number of subjects: 824
Study 34738518 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day treatment
Number of subjects: 824
Study 34738518 — intervention group
Group type: COMPARATOR
Intervention: 3-day treatment
Number of subjects: 824
Study 34738518 — intervention group
Group type: EXPERIMENTAL
Intervention: Both doses and durations
Number of subjects: 824
Study 35813410 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle massage
Number of subjects: 120
Study 35813410 — intervention group
Group type: COMPARATOR
Intervention: Control group (estradiol valerate and progesterone without pelvic floor muscle massage)
Number of subjects: 120
Study 34547084 — intervention group
Group type: EXPERIMENTAL
Intervention: School-wide IPM program
Number of subjects: 236
Study 34547084 — intervention group
Group type: COMPARATOR
Intervention: Sham HEPA filter purifiers
Number of subjects: 236
Study 34547084 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom HEPA filter purifiers
Number of subjects: 236
Study 34547084 — intervention group
Group type: COMPARATOR
Intervention: No IPM
Number of subjects: 236
Study 32962487 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab plus fufang xueshuantong capsule (cFXST)
Number of subjects: 38
Study 32962487 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab alone
Number of subjects: 38
Study 34535610 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clindamycin 1% solution combined with LAight® therapy (8 bi-weekly treatments)
Number of subjects: 81
Study 34535610 — intervention group
Group type: COMPARATOR
Intervention: Topical clindamycin 1% solution only
Number of subjects: 81
Study 32746749 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted TSH levels
Number of subjects: 0
Study 32746749 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted BMI
Number of subjects: 0
Study 33802651 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet with Placebo (KD + PL)
Number of subjects: 12
Study 33802651 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet with Ketone Supplement (KD + KS)
Number of subjects: 12
Study 33802651 — intervention group
Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 12
Study 33036554 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block at the proximal end
Number of subjects: 62
Study 33036554 — intervention group
Group type: COMPARATOR
Intervention: Continuous adductor canal block at the middle of the canal
Number of subjects: 62
Study 34984477 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 96
Study 34984477 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 34416788 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal laser therapy (micropulse laser or argon laser coagulation) for treating leakage points visible in fluorescein angiography (FA)
Number of subjects: 0
Study 34416788 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 0
Study 34416788 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic administration of mineralocorticoid receptor antagonists, carbonic anhydrase inhibitors, or non-steroidal anti-inflammatory drugs
Number of subjects: 0
Study 34416788 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 0
Study 33207606 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot powder providing 200 mg nitrate
Number of subjects: 18
Study 33207606 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot with 0.8 g of L-arginine
Number of subjects: 18
Study 33207606 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot with 1.5 g of L-arginine
Number of subjects: 18
Study 33207606 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot with 3.0 g of L-arginine
Number of subjects: 18
Study 33207606 — intervention group
Group type: COMPARATOR
Intervention: Control meal (without beetroot)
Number of subjects: 18
Study 35337274 — intervention group
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 132
Study 35337274 — intervention group
Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 132
Study 34587703 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload of low-intensity-cooked yam paste (10 g) before rice meal
Number of subjects: 18
Study 34587703 — intervention group
Group type: COMPARATOR
Intervention: Coingested low-intensity-cooked yam paste with rice
Number of subjects: 18
Study 34587703 — intervention group
Group type: EXPERIMENTAL
Intervention: Preload of medium-intensity-cooked yam paste before rice meal
Number of subjects: 18
Study 34587703 — intervention group
Group type: COMPARATOR
Intervention: Coingested medium-intensity-cooked yam paste with rice
Number of subjects: 18
Study 35951113 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 30
Study 35951113 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 33591858 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (20/10/3 g)
Number of subjects: 24
Study 33591858 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30/3 g)
Number of subjects: 24
Study 33591858 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 24
Study 33591858 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 24
Study 32836016 — intervention group
Group type: EXPERIMENTAL
Intervention: Exosomal TDP‐43 ratio
Number of subjects: 18
Study 32836016 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofilament light chain (NFL)
Number of subjects: 18
Study 32836016 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorylated neurofilament heavy chain (pNFH)
Number of subjects: 18
Study 35085715 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverse-planned intensity modulated radiation therapy
Number of subjects: 181
Study 35085715 — intervention group
Group type: COMPARATOR
Intervention: Forward-planned intensity modulated radiation therapy
Number of subjects: 181
Study 35085715 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintaining the LV volume receiving 5 Gy and 10 Gy
Number of subjects: 181
Study 35381737 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model based on multi-phase CT images (P + A + V)
Number of subjects: 195
Study 35381737 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics model including CT reports of LNM
Number of subjects: 195
Study 35777031 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic TEP inguinal hernia repair (group A)
Number of subjects: 174
Study 35777031 — intervention group
Group type: COMPARATOR
Intervention: Lichtenstein tension-free mesh repair (group B)
Number of subjects: 174
Study 35234673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesvacumab 3 mg + aflibercept 2 mg (LD combo)
Number of subjects: 302
Study 35234673 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesvacumab 6 mg + aflibercept 2 mg (HD combo)
Number of subjects: 302
Study 35234673 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept injection (IAI) 2 mg
Number of subjects: 302
Study 33197396 — intervention group
Group type: EXPERIMENTAL
Intervention: Early ECMO‐facilitated resuscitation
Number of subjects: 30
Study 33197396 — intervention group
Group type: COMPARATOR
Intervention: Standard ACLS treatment
Number of subjects: 30
Study 36198470 — intervention group
Group type: EXPERIMENTAL
Intervention: Person-centred support programme (RESPECT intervention)
Number of subjects: 41
Study 36198470 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 32961334 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial arrhythmias
Number of subjects: 4028
Study 32961334 — intervention group
Group type: COMPARATOR
Intervention: No atrial arrhythmias
Number of subjects: 4028
Study 34355327 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigenous ecological knowledge (IEK) based management of ecosystem services (ESs)
Number of subjects: 0
Study 34355327 — intervention group
Group type: EXPERIMENTAL
Intervention: Socio-demographic attributes
Number of subjects: 0
Study 34355327 — intervention group
Group type: EXPERIMENTAL
Intervention: Indigenous ecological belief systems
Number of subjects: 0
Study 33878461 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon α‐2b spray
Number of subjects: 668
Study 33878461 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin Aerosol
Number of subjects: 668
Study 36434768 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPA breaks (5-minute walk every 25 minutes)
Number of subjects: 21
Study 36434768 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively demanding activities (COGN)
Number of subjects: 21
Study 36434768 — intervention group
Group type: COMPARATOR
Intervention: LIPA breaks (INTERRUPT)
Number of subjects: 21
Study 36434768 — intervention group
Group type: COMPARATOR
Intervention: Sitting without a demanding cognitive task (SIT)
Number of subjects: 21
Study 36434768 — intervention group
Group type: COMPARATOR
Intervention: Sitting with a demanding cognitive task (COGN)
Number of subjects: 21
Study 35010877 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa powder
Number of subjects: 60
Study 35010877 — intervention group
Group type: EXPERIMENTAL
Intervention: Red berries mixture
Number of subjects: 60
Study 35010877 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cocoa and red berries
Number of subjects: 60
Study 35010877 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 35853271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervicovaginal fetal fibronectin (qfFN) concentration with Arabin pessary in situ
Number of subjects: 0
Study 35853271 — intervention group
Group type: COMPARATOR
Intervention: Cervicovaginal fetal fibronectin (qfFN) concentration without Arabin pessary
Number of subjects: 0
Study 35853271 — intervention group
Group type: COMPARATOR
Intervention: Cervical length (CL) measurement without Arabin pessary
Number of subjects: 0
Study 35853271 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical length (CL) measurement with Arabin pessary in situ
Number of subjects: 0
Study 32070406 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic arm-assisted functionally aligned TKA (FA TKA)
Number of subjects: 100
Study 32070406 — intervention group
Group type: COMPARATOR
Intervention: Robotic arm-assisted mechanically aligned TKA (MA TKA)
Number of subjects: 100
Study 35878179 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A)
Number of subjects: 80
Study 35878179 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (placebo control group)
Number of subjects: 80
Study 33704047 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency anemia (IDA) with restless legs syndrome (RLS)
Number of subjects: 124
Study 33704047 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron deficiency anemia (IDA) without restless legs syndrome (RLS)
Number of subjects: 124
Study 33704047 — intervention group
Group type: COMPARATOR
Intervention: Idiopathic restless legs syndrome (RLS)
Number of subjects: 124
Study 36174817 — intervention group
Group type: EXPERIMENTAL
Intervention: SCR BT
Number of subjects: 53
Study 36174817 — intervention group
Group type: EXPERIMENTAL
Intervention: SCR HD
Number of subjects: 53
Study 36174817 — intervention group
Group type: EXPERIMENTAL
Intervention: SCR BT and SCR HD
Number of subjects: 53
Study 33791945 — intervention group
Group type: EXPERIMENTAL
Intervention: Siponimod
Number of subjects: 0
Study 33791945 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta‐1a
Number of subjects: 0
Study 32720113 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarrhoea Management Diary (DMD)
Number of subjects: 62
Study 35014156 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD4017
Number of subjects: 93
Study 35014156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 34289889 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemostatic agent
Number of subjects: 90
Study 34289889 — intervention group
Group type: COMPARATOR
Intervention: Suturing
Number of subjects: 90
Study 35510397 — intervention group
Group type: EXPERIMENTAL
Intervention: Transportation to thrombectomy-capable center
Number of subjects: 1401
Study 35510397 — intervention group
Group type: COMPARATOR
Intervention: Transportation to local stroke center
Number of subjects: 1401
Study 33226542 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Control IPEP
Number of subjects: 47
Study 33226542 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Control+ IPEP
Number of subjects: 47
Study 33556574 — intervention group
Group type: EXPERIMENTAL
Intervention: NBD-modified peptides selected from a phage library
Number of subjects: 0
Study 32668833 — intervention group
Group type: EXPERIMENTAL
Intervention: Interscalene brachial plexus block (ISB) with 15 ml of 0.5% ropivacaine
Number of subjects: 60
Study 32668833 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior suprascapular nerve block (SSB) with 15 ml of 0.5% ropivacaine
Number of subjects: 60
Study 32668833 — intervention group
Group type: COMPARATOR
Intervention: Posterior suprascapular nerve block (SSB) with 15 ml of 0.5% ropivacaine
Number of subjects: 60
Study 34134880 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness‐Oriented Recovery Enhancement (MORE) plus methadone TAU (n = 15)
Number of subjects: 30
Study 34134880 — intervention group
Group type: COMPARATOR
Intervention: Methadone TAU only (n = 15)
Number of subjects: 30
Study 32142372 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 16
Study 32142372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 36166132 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex)
Number of subjects: 44
Study 36166132 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 44
Study 34419121 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive before questionnaire return (£15 gift voucher)
Number of subjects: 923
Study 34419121 — intervention group
Group type: COMPARATOR
Intervention: Incentive after questionnaire return (£15 gift voucher)
Number of subjects: 923